Literature DB >> 21226580

Iron-chelating therapy for transfusional iron overload.

Gary M Brittenham1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21226580      PMCID： PMC3078566          DOI： 10.1056/NEJMct1004810

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  41 in total

Review 1.  Controversies surrounding iron chelation therapy for MDS.

Authors:  Heather A Leitch
Journal:  Blood Rev       Date:  2010-10-27       Impact factor: 8.250

2.  High doses of deferiprone may be associated with cerebellar syndrome.

Authors:  F Beau-Salinas; M A Guitteny; J Donadieu; A P Jonville-Bera; E Autret-Leca
Journal:  BMJ       Date:  2009-01-22

Review 3.  Guidelines for the diagnosis and management of aplastic anaemia.

Authors:  Judith C W Marsh; Sarah E Ball; Jamie Cavenagh; Phil Darbyshire; Inderjeet Dokal; Edward C Gordon-Smith; Jane Keidan; Andrew Laurie; Anna Martin; Jane Mercieca; Sally B Killick; Rhona Stewart; John A L Yin
Journal:  Br J Haematol       Date:  2009-08-10       Impact factor: 6.998

Review 4.  The inherited diseases of hemoglobin are an emerging global health burden.

Authors:  David J Weatherall
Journal:  Blood       Date:  2010-03-16       Impact factor: 22.113

5.  Long-term outcome of continuous 24-hour deferoxamine infusion via indwelling intravenous catheters in high-risk beta-thalassemia.

Authors:  B A Davis; J B Porter
Journal:  Blood       Date:  2000-02-15       Impact factor: 22.113

6.  Tailoring iron chelation by iron intake and serum ferritin: the prospective EPIC study of deferasirox in 1744 patients with transfusion-dependent anemias.

Authors:  Maria Domenica Cappellini; John Porter; Amal El-Beshlawy; Chi-Kong Li; John F Seymour; Mohsen Elalfy; Norbert Gattermann; Stéphane Giraudier; Jong-Wook Lee; Lee Lee Chan; Kai-Hsin Lin; Christian Rose; Ali Taher; Swee Lay Thein; Vip Viprakasit; Dany Habr; Gabor Domokos; Bernard Roubert; Antonis Kattamis
Journal:  Haematologica       Date:  2009-11-30       Impact factor: 9.941

7.  Consensus statement on iron overload in myelodysplastic syndromes.

Authors:  John M Bennett
Journal:  Am J Hematol       Date:  2008-11       Impact factor: 10.047

8.  Pharmacokinetics, metabolism, and disposition of deferasirox in beta-thalassemic patients with transfusion-dependent iron overload who are at pharmacokinetic steady state.

Authors:  Felix Waldmeier; Gerard J Bruin; Ulrike Glaenzel; Katharine Hazell; Romain Sechaud; Steve Warrington; John B Porter
Journal:  Drug Metab Dispos       Date:  2010-01-22       Impact factor: 3.922

9.  Specific iron chelators determine the route of ferritin degradation.

Authors:  Ivana De Domenico; Diane McVey Ward; Jerry Kaplan
Journal:  Blood       Date:  2009-08-11       Impact factor: 22.113

10.  Nutritional deficiencies in iron overloaded patients with hemoglobinopathies.

Authors:  Susan Claster; John C Wood; Leila Noetzli; Susan M Carson; Thomas C Hofstra; Rachna Khanna; Thomas D Coates
Journal:  Am J Hematol       Date:  2009-06       Impact factor: 10.047
View more
  106 in total

1.  Prevention of radiation-induced bone pathology through combined pharmacologic cytoprotection and angiogenic stimulation.

Authors:  Alexis Donneys; Noah S Nelson; Joseph E Perosky; Yekaterina Polyatskaya; Jose J Rodriguez; Christian Figueredo; Cheyenne A Vasseli; Hannah C Ratliff; Sagar S Deshpande; Kenneth M Kozloff; Steven R Buchman
Journal:  Bone       Date:  2015-12-23       Impact factor: 4.398

Review 2.  The exochelins of pathogenic mycobacteria: unique, highly potent, lipid- and water-soluble hexadentate iron chelators with multiple potential therapeutic uses.

Authors:  Lawrence D Horwitz; Marcus A Horwitz
Journal:  Antioxid Redox Signal       Date:  2014-06-20       Impact factor: 8.401

Review 3.  Iron chelation therapy in myelodysplastic syndromes: where do we stand?

Authors:  Mhairi Mitchell; Steven D Gore; Amer M Zeidan
Journal:  Expert Rev Hematol       Date:  2013-08       Impact factor: 2.929

4.  Prevalence and management of iron overload in pyruvate kinase deficiency: report from the Pyruvate Kinase Deficiency Natural History Study.

Authors:  Eduard J van Beers; Stephanie van Straaten; D Holmes Morton; Wilma Barcellini; Stefan W Eber; Bertil Glader; Hassan M Yaish; Satheesh Chonat; Janet L Kwiatkowski; Jennifer A Rothman; Mukta Sharma; Ellis J Neufeld; Sujit Sheth; Jenny M Despotovic; Nina Kollmar; Dagmar Pospíšilová; Christine M Knoll; Kevin Kuo; Yves D Pastore; Alexis A Thompson; Peter E Newburger; Yaddanapudi Ravindranath; Winfred C Wang; Marcin W Wlodarski; Heng Wang; Susanne Holzhauer; Vicky R Breakey; Madeleine Verhovsek; Joachim Kunz; Melissa A McNaull; Melissa J Rose; Heather A Bradeen; Kathryn Addonizio; Anran Li; Hasan Al-Sayegh; Wendy B London; Rachael F Grace
Journal:  Haematologica       Date:  2018-09-13       Impact factor: 9.941

5.  ROS-triggered degradable iron-chelating nanogels: Safely improving iron elimination in vivo.

Authors:  Zhi Liu; Jing Qiao; Tamas Nagy; May P Xiong
Journal:  J Control Release       Date:  2018-05-22       Impact factor: 9.776

Review 6.  The long history of iron in the Universe and in health and disease.

Authors:  Alex D Sheftel; Anne B Mason; Prem Ponka
Journal:  Biochim Biophys Acta       Date:  2011-08-09

7.  Multifunctional Polymeric Micelles for Combining Chelation and Detection of Iron in Living Cells.

Authors:  Zhi Liu; Max Purro; Jing Qiao; May P Xiong
Journal:  Adv Healthc Mater       Date:  2017-06-29       Impact factor: 9.933

8.  Management of iron overload in myelodysplastic syndromes: combined deferasirox and deferoxamine in a patient with liver disease.

Authors:  Claudio Cerchione; Giuseppe Cerciello; Simona Avilia; Roberta Della Pepa; Novella Pugliese; Marco Picardi; Lucio Catalano; Fabrizio Pane
Journal:  Blood Transfus       Date:  2016-10-24       Impact factor: 3.443

9.  Can multi-slice or navigator-gated R2* MRI replace single-slice breath-hold acquisition for hepatic iron quantification?

Authors:  Ralf B Loeffler; M Beth McCarville; Anne W Wagstaff; Matthew P Smeltzer; Axel J Krafft; Ruitian Song; Jane S Hankins; Claudia M Hillenbrand
Journal:  Pediatr Radiol       Date:  2016-10-17

10.  Serum Iron and Ferritin Levels Are Correlated with Complement C3.

Authors:  Shuang Wen; Yeqin Sha; Yinling Li; Zhilian Rui; Chenhong Si; Yuning Zhou; Fengfeng Yan; Bicheng Wang; Jingming Hu; Xu Han; Dongyan Shi
Journal:  Biol Trace Elem Res       Date:  2020-09-15       Impact factor: 3.738
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.